Background. Interstitial eosinophilic aggregates (IEA) in renal biopsies often suggest allergic tubulointerstitial nephritis, yet clear associations with drug reactions are often difficult to establish. IEA are also encountered in diabetic nephropathy (DN) and thought to be attributed to medication exposure. Methods. Native medical kidney biopsies performed at the University of Washington Medical Center were reviewed, including DN (n = 64), IgA nephropathy (IgAN, n = 28), membranous nephropathy (MN, n = 14), focal and segmental glomerulosclerosis (FSGS, n = 27) and membranoproliferative glomerulonephritis (MPGN, n = 28). IEA were defined as ≥5 eosinophils per high power field. The severity of interstitial fibrosis and tubular atrophy (IFTA) was scored semi-quantitatively as minimal, mild, moderate or severe. Results. IEA were remarkably more prevalent in DN (41%), when compared with IgAN (7%, P = 0.001), MN (8%, P = 0.017) or MPGN (14%, P = 0.013), but not FSGS (26%, P = 0.18). In DN cases, univariate analysis revealed that IEA were associated with greater IFTA severity, but not with the percentage of glomerulosclerosis, mesangial expansion, history of drug allergy, number of prescribed medications or particular class of medications (antibiotics, NSAIDs, aspirin, thiazide, loop diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, beta blockers, insulin, sulfonylurea, metformin or allopurinol). Multivariate analysis showed that the severity of IFTA was the only significant predictor for IEA (P < 0.01) after stepwise adjustment for age, number of medications, drug allergy, diabetes type, % global glomerulosclerosis and mesangial expansion.
A B S T R AC T
Background. Interstitial eosinophilic aggregates (IEA) in renal biopsies often suggest allergic tubulointerstitial nephritis, yet clear associations with drug reactions are often difficult to establish. IEA are also encountered in diabetic nephropathy (DN) and thought to be attributed to medication exposure. Methods. Native medical kidney biopsies performed at the University of Washington Medical Center were reviewed, including DN (n = 64), IgA nephropathy (IgAN, n = 28), membranous nephropathy (MN, n = 14), focal and segmental glomerulosclerosis (FSGS, n = 27) and membranoproliferative glomerulonephritis (MPGN, n = 28). IEA were defined as ≥5 eosinophils per high power field. The severity of interstitial fibrosis and tubular atrophy (IFTA) was scored semi-quantitatively as minimal, mild, moderate or severe. Results. IEA were remarkably more prevalent in DN (41%), when compared with IgAN (7%, P = 0.001), MN (8%, P = 0.017) or MPGN (14%, P = 0.013), but not FSGS (26%, P = 0.18). In DN cases, univariate analysis revealed that IEA were associated with greater IFTA severity, but not with the percentage of glomerulosclerosis, mesangial expansion, history of drug allergy, number of prescribed medications or particular class of medications (antibiotics, NSAIDs, aspirin, thiazide, loop diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, beta blockers, insulin, sulfonylurea, metformin or allopurinol). Multivariate analysis showed that the severity of IFTA was the only significant predictor for IEA (P < 0.01) after stepwise adjustment for age, number of medications, drug allergy, diabetes type, % global glomerulosclerosis and mesangial expansion.
Conclusions. Our study shows that IEA are more common in DN, when compared with other types of glomerulopathy. In DN, IEA are associated with the severity of IFTA but not with prescribed medications or clinical history of allergy. This suggests that in DN IEA are often associated with chronic tubulointerstitial injury and are not diagnostic of an allergic interstitial nephritis.
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I N T RO D U C T I O N
Diabetic nephropathy (DN) is by far the leading cause of endstage renal diseases (ESRD) in the USA [1] . The pathology of DN involves all components of renal cortex, including glomeruli, tubulointerstitium and blood vessels. The glomerular changes are characterized by thickening of glomerular basement membranes, mesangial expansion and mesangiolysis resulting in remodeling of mesangial matrix and formation of nodules (i. e. Kimmelstiel-Wilson nodules). The tubulointerstitial changes include thickening of tubular basement membranes, followed by tubular atrophy and interstitial fibrosis (IFTA) which is often associated with interstitial inflammation with predominantly mononuclear cell infiltrate. The vascular changes demonstrate arteriolar hyalinosis and intimal sclerosis of arterial walls [2] .
In diabetic patients, renal biopsy is indicated in patients with progressive proteinuria or renal functional impairment that is unexplained by diabetes and raises concern for superimposed pathologic conditions [3] [4] [5] . In addition to hypertensive nephrosclerosis and acute tubular injury, tubulointerstitial nephritis is a common superimposed pathologic finding reported in patients with DN [6] . Typical inflammatory infiltrates of interstitial nephritis include both lymphocytes and monocytes/ macrophages, while the presence of neutrophils or plasma cells can sometimes point to an infectious etiology.
Eosinophils may be detected among the inflammatory cells in DN. The presence of interstitial eosinophilic aggregates (IEA) is the hallmark of drug-induced tubulointerstitial nephritis; however, this finding can also be seen in other conditions, including autoimmune diseases, tubulointerstitial nephritis with uveitis [7] , eosinophilic polyangiitis (Churg-Strauss syndrome) [8] and parasitic infections [9] . Furthermore, it is not uncommon to identify IEA adjacent to disrupted tubules or chronic tubulointerstitial injury in DN. Because diabetic patients commonly take multiple medications, the presence of IEA in renal biopsies from these patients is commonly interpreted as allergic drug reaction. However, additional evidence to support a hypersensitivity reaction as a potential etiology for renal dysfunction is often difficult to establish in clinical practice. Therefore, the commonly presumed relationship between IEA and drug-induced tubulointerstitial nephritis in kidney biopsies with DN needs to be validated. In the present study, we examined if the finding of IEA is more common in DN than other glomerulopathies and if a relationship between specific medication and presence of IEA could be established.
M AT E R I A L S A N D M E T H O D S

Case selection
Our study was approved by the Institutional Review Board of the University of Washington (IRB # 42 719). We used our institutional pathology database to search for all native kidney biopsies performed at the University of Washington Medical Center between January 2000 and November 2011. All consecutive biopsies with a diagnosis of DN (n = 64) or other glomerulopathies, including IgA nephropathy (IgAN) (n = 28), membranous nephropathy (MN) (n = 14), focal and segmental glomerulosclerosis (FSGS) (n = 27) and membranoproliferative glomerulonephritis (MPGN) (n = 28), were included in our study. Our exclusion criteria were lupus nephritis, biopsies with overlapping or more than one glomerular injury process, biopsies with indeterminate types of glomerulonephritis, patients with known malignancy and systemic vasculitis.
Tissue preparation
All renal biopsies were processed by standard methods for light, immunofluorescence and electron microscopy. For light microscopic evaluation, 2-μm histologic sections from formalin-fixed paraffin-embedded tissue were stained with hematoxylin and eosin (H&E), periodic acid-Schiff (PAS), Jones methenamine silver and trichrome stains. For immunofluorescence studies, 4-μm cryostat sections were stained with fluorescein isothiocyanate-conjugated anti-human IgG, IgM, IgA, C3, C1q, κ and λ light chain, fibrinogen and albumin (Dako, Carpinteria, CA) following a standard protocol. The immunofluorescence was evaluated for distribution and pattern, and the intensity was documented using a semi-quantitative 0 to 4+ score. Tissue for electron microscopy was fixed in Karnovsky solution, then post-fixed in 1% osmium tetroxide, dehydrated in a graded ethanol series and embedded in Polybed 812 (Polysciences, Inc., Warrington, PA). Thin sections were stained with uranyl acetate and lead citrate and examined by transmission electron microscopy.
Clinical data and prescribed medication Clinical and demographical data including age, gender, type 1 or type 2 diabetes, clinical indication of renal biopsy, such as proteinuria, nephrotic syndrome, hematuria, acute kidney injury, elevated serum creatinine (sCr) or abnormal serological examinations, were obtained from electronic medical records.
For patients with DN, a listing of prescribed medications was obtained from electronic prescription records and clinical notes. All medications were extensively reviewed and grouped accordingly into one of 19 categories, including non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, acetaminophen, oxycodone and opioid analgesics, aspirin, statins, fibrates, allopurinol, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), thiazide and loop diuretics, calcium channel blockers, spironolactone, sulfonylureas, metformin, insulin, calcium and vitamins. The total number of medications was also recorded and history of drug allergy was documented.
Definition of pathological lesions and semi-quantitative grading of histological parameters
The light microscopy slides from the selected cases were retrieved from our archives for the following assessments. Total biopsy core length, total number of glomeruli per level section and % global glomerulosclerosis were obtained from pathology reports. Other histological parameters (see below) were obtained by examination of Jones methenamine silver-stained slides which were reviewed specifically for this study. The presence of interstitial extravasated Tamm-Horsfall protein was examined on PAS-stained slides and association of this finding with eosinophilic aggregates was examined on adjacent H&E slides.
The histologic severity of chronic tubulointerstitial injury was semi-quantitatively scored as minimal to mild if interstitial fibrosis and tubular atrophy (IFTA) involved 0-25% (IFTA = 1); as moderate if IFTA involved >25% but ≤50% of cortex (IFTA = 2); and as severe if IFTA involved >50% of the sampled renal cortex (IFTA = 3). Mesangial expansion severity was determined semi-quantitatively based on the average estimated percentage of glomerular tuft which was occupied by mesangium as follows: minimal, <10%; mild, 11-25%; moderate, 26-50% and severe, >50%. The presence of nodular mesangial expansion was recorded. Also, it was recorded if mesangial expansion was predominantly (in over half of the glomeruli) diffuse or nodular. Arteriosclerosis score was determined semiquantitatively based on the estimated percentage of the nontangential arterial profile area confined by lamina elastic interna that is occupied by intimal fibrosis in the most severely affected vessel, as follows: minimal, <10%; mild, 11-25%; moderate, 25-50% and severe, >50%. Arteriolar hyalinosis score was determined semi-quantitatively based on the estimated percentage of the arteriolar wall occupied by hyaline as follows: none, mild, 1-25%; moderate, 25-50% and severe, >50%.
IEA were defined as the presence of ≥5 eosinophils in the interstitium in at least one high-power field (HPF) with ×40 objective magnification. The location (cortex, medulla, corticomedullary junction or both cortex and medulla) and the number (<3, 3-4 or ≥5 foci) of IEA were recorded. Distribution of tubulitis, if present, in atrophic, non-atrophic tubules or both was determined. Eosinophilic tubulitis was defined as the presence of eosinophilic infiltration of tubular epithelial cells. Interstitial neutrophilic aggregates were defined as the presence of ≥5 neutrophils per HPF. Interstitial mononuclear cell inflammation was semi-quantitatively scored as minimal to mild, when involving <25% of renal parenchyma; and as moderate or severe when involving 25-50% or >50% of renal parenchyma, respectively. Distribution of interstitial inflammation (cortex, medulla; areas with IFTA, no IFTA or both) was recorded.
Statistical analysis
Continuous variables were presented as mean ± standard error of the mean, and compared using the two-tailed t test (Tables 1-3) or one-way ANOVA, followed by Sidak post hoc analysis (Table 1) . Categorical variables were compared using the χ 2 or Fisher's exact test, whenever appropriate. To elucidate factors independently associated with IEA, we applied multivariate logistic regression analysis to adjust for age, gender, % global glomerulosclerosis and IFTA score. In subset analysis of DN, two models were tested. The first model included IFTA and other potential confounders, including age, %global glomerulosclerosis and mesangial expansion score, history of allergy, total number of prescribed medications and type 1 versus type 2 diabetes. The second model was generated using a stepwise forward selection method, which included any analyzed factors with a significance level of P < 0.3 to be included into the model. P-values <0.05 were considered statistically significant. All statistical analyses were performed using Stata IC version 10 (College Station, TX).
R E S U LT S
Demographic and clinical characteristics of subjects are summarized in Table 1 . Patients with DN were significantly older than those with IgAN (P < 0.001), MN (P = 0.006) and FSGS (P = 0.035). Patients with DN were more likely to be male (57%) than those with MN (21%, P = 0.013), but the proportion of male gender in IgAN (39%), FSGS (56%) and MPGN (60%) were comparable with that in DN.
The histopathological characteristics are summarized in Figure 1 . The average biopsy length (cm) and the number of glomeruli available in the biopsies were not different among the type of glomerulopathies examined. IEA was much more commonly found in DN (41%), compared with IgAN (7%; P = 0.0013), MN (8%; P = 0.017) or MPGN (14%; P = 0.013); however, the prevalence of IEA in DN was higher but not statistically different from FSGS (26%; P = 0.18). Likewise, moderate-to-severe IFTA was more commonly found in biopsies with DN (70%) compared with those with IgAN (18%; P < 0.001), MN (36%; P = 0.014) or MPGN (7%; P < 0.001) or FSGS (41%; P = 0.008). As expected, moderate-to-severe arteriolar hyalinosis was significantly more prevalent in DN (58%) than IgAN (4%; P < 0.001), MN (0%; P < 0.001), MPGN (0%; P < 0.001) or FSGS (22%; P = 0.002). These findings demonstrated that the increased prevalence of IEA in DN was paralleled by the increased prevalence in moderate-to-severe IFTA and arteriolar hyalinosis. Using multivariate logistic regression analysis, we discovered that DN and the presence of moderateto-severe IFTA were both significant predictors for the presence of IEA, with the OR of 2.76 (P = 0.03) and 2.79 (P = 0.001), respectively, after adjustment for age, gender and % global glomerulosclerosis ( Table 2 ). The % global glomerulosclerosis or presence of moderate-to-severe arteriosclerosis was not different among the various glomerulopathies examined.
To define other factors associated with the higher prevalence of IEA in DN, we compared the clinical and pathological features of DN patients with and without IEA. The proportions of clinical presentation of proteinuria, hematuria or renal functional impairment leading to renal biopsy were not significantly different in DN patients with IEA compared with those without IEA (Table 3) . However, DN patients with IEA more commonly had severe IFTA on biopsies compared with those without IEA ( Table 3) . IEA were also accompanied by interstitial edema in 62%, and eosinophilic tubulitis in 12% of DN biopsies (Table 3) , indicative of activity of the tublointerstitial nephritis. In half of the DN biopsies with IEA and tubulitis, tubulitis was present either only in the non-atrophic tubules (20%) or in both atrophic and non-atrophic tubules (30%), while in the rest of these biopsies, tubulitis was present only in the atrophic tubules. Since IEA are sometimes seen in response to extravasation of Tamm Horsfall protein, we examined the association between these two findings. Extravasated Tamm Horsfall protein was found in 15.8% of DN without IEA and only in 7.7% (2 cases) of DN with IEA (P = 0.34). However, in both cases of DN with IEA and extravasated Tamm Horsfall protein, the eosinophilic aggregates were located in close proximity to the extravasated material.
The percentage of globally sclerosed glomeruli, the proportion of biopsies with predominantly nodular mesangial sclerosis, the presence of Kimmelstiel-Wilson nodule, the severity of mesangial sclerosis, the proportion of interstitial neutrophilic aggregates, moderate-to-severe arteriosclerosis or moderate-to-severe arteriolar hyalinosis were not different between biopsies of DN with IEA versus DN without IEA. Likewise, analysis of clinical data revealed no difference in mean age, serum creatinine, sex, diabetes type, the presence of nephrotic syndrome, acute renal failure, hemodialysis treatment or history of allergy between diabetic patients with and those without IEA.
IEA in DN were predominantly located in cortical parenchyma (88%), of which 62% were found within areas with IFTA ( Figure 2 ). The distribution of IEA was focal in majority of DN biopsies (62%) with 1-3 foci of IEA, while 35% of biopsies had 4 or 5 foci, and one case (4%) had extensive IEA with more than 5 foci.
To elucidate the relationship between the prescribed medications and the presence of IEA in kidney biopsies, we extensively reviewed the prescribed medications in patients with DN (Table 4) . None of the 19 drugs or drug classes documented in patients' electronic medical records (see Patients and Methods) was found to be more commonly used in DN patients with versus those without IEA. Furthermore, the total number of medications taken was virtually similar in DN patients with or without IEA (8.5 ± 0.7 for both). Thus, neither individual drug class nor total number of prescribed medications correlated with the presence of IEA in patients with DN. Using multivariate logistic regression analyses and adjusting for IFTA score, age, % global glomerulosclerosis and mesangial expansion score, history of allergy, total number of prescribed medications and diabetes type (Table 4 , Model 1), IFTA score is the only statistically significant predictor for the presence of IEA [β = 1.738, 95% confidence interval (CI) = 0.563, 2.913, P = 0.004]. Using an unbiased stepwise forward selection method (Table 4 , Model 2) with a significance cutoff level of P < 0.3 for any factors (including individual medications) to be included into the model, five parameters (chronic IFTA, age, the use of loop diuretics, statin and ACEI) were included into the model (all with P < 0.3). In this analysis, similar to Model 1, IFTA is the only significant predictor of IEA (β = 1.825, 95% CI = 0.642, 3.009, P = 0.003).
D I S C U S S I O N
Diabetes is an epidemic disease, with ∼25-50% of patients developing DN and a significant proportion of these eventually progressing to end-stage renal failure [1, 10] . Renal pathological changes in patients with diabetes are not always attributable to DN [3] . Approximately 10-30% of clinical kidney biopsies from diabetic patients show concurrent non-diabetic renal F I G U R E 2 : Several foci of IEA mixed with mononuclear leukocytes are present within fibrotic cortical parenchyma in a case of diabetic nephropathy. pathologies that may precipitate the progressive loss of renal function [3, 5, 6] . Soni et al. reported acute interstitial nephritis to be the most common concurrent non-diabetic pathology in clinical kidney biopsies from type 2 diabetic patients [6] . IEA are commonly encountered in acute interstitial nephritis and are often suggestive of allergic-type interstitial nephritis due to hypersensitivity to drugs.
In the current study, we demonstrate that IEA were more prevalent in DN (41%) when compared with other glomerulopathies (7-26%), and they are associated with an increased proportion of moderate-to-severe IFTA. Multivariate analysis revealed that the presence of DN and moderateto-severe IFTA are both significant predictors of IEA, after adjustment for age, gender and % of global glomerulosclerosis (Table 2) . In DN cases, IEA were most commonly found within fibrotic cortical parenchyma, adjacent to the area of IFTA ( Figure 2 ) and frequently associated with interstitial mononuclear cell inflammatory infiltrate, interstitial edema and tubulitis. Extravasated Tamm-Horsfall protein was found in 7.7% (2 cases) of DN with IEA, located in close proximity to the eosinophilic aggregates, suggesting that extravasated TH might be a cause of IEA in a small fraction of DN with IEA cases.
Diabetic patients typically take many prescribed medications to control blood glucose, hypertension, hypercholesterolemia, hyperuricemia and diabetic-related infection. Some of these drugs have been associated with allergic interstitial nephritis, such as antibiotics, NSAIDs, oxycodone, thiazides and loop diuretics and allopurinol, among others. Thus, it was thought that the increased prevalence of IEA in DN might be a manifestation of allergic/hypersensitivity reaction to drugs. In this study, extensive review of the prescribed medications reveals that DN patients with or without IEA were taking a similar number and classes of prescribed medications (Table 4) . Thus, we failed to find supportive evidence to implicate medications as culprits for IEA in DN patients. Multivariate analyses demonstrated that the severity of chronic IFTA was the only significant predictor of IEA in DN (Table 5) .
Allergic-type acute interstitial nephritis often manifests as acute renal functional impairment. The lack of association between IEA and acute renal failure in DN does not support a diagnosis of allergic-type acute interstitial nephritis. This finding is especially important since management of allergic-type interstitial nephritis may require prescribing steroids which complicates diabetes control and may impose additional risks.
Progressive IFTA is often closely linked to glomerular filtration rate decline in chronic kidney disease of various etiologies. In fact, some studies have argued that renal dysfunction in diabetes is primarily consequent to interstitial rather than glomerular lesions [11, 12] . However, at least in type 1 diabetes, glomerular lesions are more important determinants of renal dysfunction early on, whereas IFTA may become a stronger predictor of progression from established renal insufficiency to terminal uremia [13, 14] . In addition to the degree of proteinuria [15] and hypertension [16, 17] , the biopsy features of tubulointerstitial fibrosis [18] , myofibroblast accumulation [19, 20] and interstitial macrophages [20] have been shown to be of prognostic value for progression to renal failure in DN. To our knowledge, the current study is the first to suggest a possible direct association between DN chronic injury and IEA. However, Fukui et al. showed that peripheral blood eosinophil count independent of diabetes duration, HbA1C, systolic blood pressure and serum triglyceride directly correlated with albumin excretion rate in type 2 diabetic males [21] , suggesting an association between peripheral blood eosinophil count and severity DN. Our study was limited by the absence of information about blood eosinophil counts or HbA1C in majority of subjects. Therefore, we were not able to confirm this association in the current study. On the other hand, although we did not identify a relationship between IEA and IFTA in other nondiabetic glomerulopathies, the specificity of this relationship to DN cannot be determined based on the current study. The effect of sampling bias in reporting prevalence of glomerulopathies other than DN in clinical biopsies from diabetic patients with proteinuria is well described in the past [22, 23] . To establish that the relationship of IFTA and IEA is specific to DN, independent of clinical presentation, an unbiased study using research ( protocol) biopsies must be performed.
In summary, our observations suggest that IEA are prevalent in DN and are not diagnostic of allergic-type interstitial nephritis. The severity of IFTA is significantly associated with IEA, suggesting that IEA in DN either represent an inflammatory response to chronic tubulointerstitial injury or that IEA are potential stimuli leading to chronic tubulointerstitial injury or both. Thus, clinical significance of IEA in renal biopsies from diabetic patients should be interpreted with caution, since their presence appears to represent a common component of chronic tubulointerstitial injury in these patients.
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